Skip to main content

and
  1. Article

    Open Access

    Inhibition of the m6A reader IGF2BP2 as a strategy against T-cell acute lymphoblastic leukemia

    T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignant leukemia with extremely limited treatment for relapsed patients. N6‐methyladenosine (m6A) reader insulin-like growth factor 2 mRNA-binding pr...

    Panpan Feng, Dawei Chen, **a Wang, Yanxia Li, Zhenyu Li, Boya Li, Yupeng Zhang in Leukemia (2022)

  2. Article

    Open Access

    Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial

    Recent evidence suggests that CD147 serves as a novel receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Blocking CD147 via anti-CD147 antibody could suppress the in vitro SAR...

    Huijie Bian, Zhao-Hui Zheng, Ding Wei in Signal Transduction and Targeted Therapy (2021)